Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3502348

Beta release

Statistics of The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells
Statistics for this year
PeriodVisitsDownloads
20244239
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0733
2024-0844
2024-0900